Pulike Biological Engineering

Pulike Biological Engineering, Inc (stock code: 603566) has firmly positioned itself as a leader in the research, development, and production of high-quality veterinary biological products and chemical drugs since its establishment in 1995. The company’s strong emphasis on scientific and technological innovation has enabled it to rapidly ascend to the forefront of the industry. With six production bases 100,000 square meters GMP-certified production workshops, and over 60 production lines, Pulike delivers an extensive array of more than 70 biological products and over 200 chemical drugs, all purposefully designed to safeguard and enhance animal health across livestock, poultry, and pets.

As a wholly-owned subsidiary of Pulike Group, Huizhong Animal Health is unwavering in its commitment to the field of pet health, innovating and producing superior pet medications built on cutting-edge technology. Its diverse product line encompasses vaccines and chemical therapies, focusing not only on protecting the lives of pets but also on significantly improving their quality of life and extending their longevity. Going forward, Huizhong Animal Health will remain resolutely driven by innovation, with an ambitious goal to establish itself as an internationally renowned brand in pet pharmaceuticals and to make substantial contributions to the global advancement of pet health.